The Limited Times

Now you can see non-English news...

Covid, Iss: high risk regions increase from 3 to 5

2022-12-09T16:57:59.541Z


Those in which the employment rate of ordinary departments exceeds the alert threshold rise from 7 to 9 (ANSA)


The regions classified as high risk for multiple resilience alerts

have increased from 3 to 5 in the last week

.

They are Emilia Romagna, Puglia, Abruzzo, Liguria and Marche.

The regions classified as moderate risk are 10 and 6 are those at low risk.

This is indicated by the table relating to the decision-making indicators of the weekly monitoring of the Istituto Superiore di Sanità (ISS) and the Ministry of Health on the progress of the Covid-19 epidemic.

The Regions in which the

occupancy rate of ordinary wards

by Covid-19 patients exceeded the alert threshold of 15% rose from 7 to 9.

They are Umbria (33.2%), Liguria (31.6%), Valle d'Aosta (28.4%), Friuli Venezia Giulia (22.9%), Emilia Romagna (19.4%%), Marche ( 18.6%), Abruzzo (18.5%%), Veneto (16.5%), Calabria (15.6%, value as at 7 December).

The occupation of intensive care is below the 10% threshold in all regions.

The highest values ​​are in Liguria (7.1%), Friuli Venezia Giulia (6.7%) and Abruzzo (6.1%).

This is revealed by the table on the decision-making indicators of the ISS-Ministry of Health monitoring.

(HANDLE).


New

Covid-19 cases still down in a week

with -2.8% (compared to last week's drop of 0.7%) while deaths register +8% (it was +9.5%).

It emerges from the weekly data published by the Ministry of Health.

In the week of 2-8 December, the ministry notes, 221,154 new positive cases were recorded against 227,440 in the previous week and 686 (635 previous figure);

1,256,722 swabs with a variation of -5.2% compared to the previous week (1,324,969);

positivity rate of 17.6% with a change of 0.4% compared to the previous week (17.2%).


The task force for the Covid emergency of the European drug agency (EMA) warns that

the monoclonal antibodies authorized today may not be effective against the emerging strains

of SarsCov2.

Designed to neutralize the virus by binding to the spike protein, mutations can reduce the ability to bind to it.

Laboratory studies, explains the EMA, show that monoclonal antibodies targeted on the spike are poorly effective in neutralizing the Omicron BA.4.6, BA.2.75.2 and XBB strains and do not significantly neutralize the BQ.1 and BQ variants. 1.1, which should become dominant in the coming weeks.   

Source: ansa

All life articles on 2022-12-09

You may like

Life/Entertain 2024-02-04T23:40:11.374Z

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.